Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ulthera, Inc
This trial is a prospective, single-site, double-blinded, randomized, split-face design. Subjects will be randomized to one of three treatment groups, receiving treatment using different energy levels. Global Aesthetic Improvement Scale scores and patient satisfaction questionnaires will be obtained.
Age
30–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female, age 30 to 65 years.
Subject in good health.
Skin laxity on the face and neck
You may not be if
Presence of an active systemic or local skin disease that may affect wound healing.
